100 related articles for article (PubMed ID: 11564260)
1. Quinacrine enhances carmustine therapy of experimental rat glioma.
Reyes S; Herrera LA; Ostrosky P; Sotelo J
Neurosurgery; 2001 Oct; 49(4):969-73. PubMed ID: 11564260
[TBL] [Abstract][Full Text] [Related]
2. Protamine inhibits angiogenesis and growth of C6 rat glioma; a synergistic effect when combined with carmustine.
Arrieta O; Guevara P; Reyes S; Ortiz A; Rembao D; Sotelo J
Eur J Cancer; 1998 Dec; 34(13):2101-6. PubMed ID: 10070318
[TBL] [Abstract][Full Text] [Related]
3. The antitumor effect of MX2, a new morpholino anthracycline, against malignant glioma cell lines and its subcellular distribution.
Kabuto M; Kubota T; Kobayashi H; Nakagawa T; Kitai R
Neurosurgery; 1995 Sep; 37(3):471-6; discussion 476-7. PubMed ID: 7501112
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the efficiency of chemotherapy in in vivo orthotopic models of human glioma cells with and without 1p19q deletions and in C6 rat orthotopic allografts serving for the evaluation of surgery combined with chemotherapy.
Branle F; Lefranc F; Camby I; Jeuken J; Geurts-Moespot A; Sprenger S; Sweep F; Kiss R; Salmon I
Cancer; 2002 Aug; 95(3):641-55. PubMed ID: 12209758
[TBL] [Abstract][Full Text] [Related]
5. Induction of β-glucuronidase release by cytostatic agents in small tumors.
Antunes IF; Haisma HJ; Elsinga PH; Di Gialleonardo V; van Waarde A; Willemsen AT; Dierckx RA; de Vries EF
Mol Pharm; 2012 Nov; 9(11):3277-85. PubMed ID: 23009590
[TBL] [Abstract][Full Text] [Related]
6. Antiproliferative effect of thalidomide alone and combined with carmustine against C6 rat glioma.
Arrieta O; Guevara P; Tamariz J; Rembao D; Rivera E; Sotelo J
Int J Exp Pathol; 2002 Apr; 83(2):99-104. PubMed ID: 12084046
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity of cis-parinaric acid in cultured malignant gliomas.
Traynelis VC; Ryken TC; Cornelius AS
Neurosurgery; 1995 Sep; 37(3):484-9. PubMed ID: 7501114
[TBL] [Abstract][Full Text] [Related]
8. O6-benzylguanine potentiates the antitumor effect of locally delivered carmustine against an intracranial rat glioma.
Rhines LD; Sampath P; Dolan ME; Tyler BM; Brem H; Weingart J
Cancer Res; 2000 Nov; 60(22):6307-10. PubMed ID: 11103789
[TBL] [Abstract][Full Text] [Related]
9. Concurrent treatment with BCNU and Gamma Knife radiosurgery in the rat malignant glioma model.
Cho KT; Kim DG; Paek SH; Chung HT; Jung HW; Park HW
J Neurol Surg A Cent Eur Neurosurg; 2012 May; 73(3):132-41. PubMed ID: 22628080
[TBL] [Abstract][Full Text] [Related]
10. PTK787/ZK222584, an inhibitor of vascular endothelial growth factor receptor tyrosine kinases, decreases glioma growth and vascularization.
Goldbrunner RH; Bendszus M; Wood J; Kiderlen M; Sasaki M; Tonn JC
Neurosurgery; 2004 Aug; 55(2):426-32; discussion 432. PubMed ID: 15271251
[TBL] [Abstract][Full Text] [Related]
11. In vitro analysis of the cellular resistance to chemotherapeutic BCNU.
Caballero Navarro A; Conde Guerri B; Sinues Porta E; Boada Apilluelo E; Alcalá Arellano A
Histol Histopathol; 1992 Jul; 7(3):347-51. PubMed ID: 1504454
[TBL] [Abstract][Full Text] [Related]
12. Laboratory studies of berberine used alone and in combination with 1,3-bis(2-chloroethyl)-1-nitrosourea to treat malignant brain tumors.
Zhang RX; Dougherty DV; Rosenblum ML
Chin Med J (Engl); 1990 Aug; 103(8):658-65. PubMed ID: 2122945
[TBL] [Abstract][Full Text] [Related]
13. Characterization of gastrin-induced cytostatic effect on cell proliferation in experimental malignant gliomas.
Lefranc F; Sadeghi N; Metens T; Brotchi J; Salmon I; Kiss R
Neurosurgery; 2003 Apr; 52(4):881-90; discussion 890-1. PubMed ID: 12657185
[TBL] [Abstract][Full Text] [Related]
14. Combined growth-inhibitory responses and ultrastructural alterations produced by 1,3-bis(2-chloroethyl)-1-nitrosourea and dexamethasone in rat glioma cell cultures.
Grasso RJ; Johnson CE; Boler RK; Moore NA
Cancer Res; 1977 Feb; 37(2):585-94. PubMed ID: 832280
[TBL] [Abstract][Full Text] [Related]
15. In vivo enhanced antitumor activity of carmustine [N,N'-bis(2-chloroethyl)-N-nitrosourea] by simvastatin.
Soma MR; Baetta R; De Renzis MR; Mazzini G; Davegna C; Magrassi L; Butti G; Pezzotta S; Paoletti R; Fumagalli R
Cancer Res; 1995 Feb; 55(3):597-602. PubMed ID: 7834630
[TBL] [Abstract][Full Text] [Related]
16. [Effect of pretreatment with N-methyl-N-nitrosourea or streptozotocin on the cytotoxicity and the induction of sister chromatid exchanges in human and rodent brain tumor cells treated with chloroethylnitrosourea].
Tokuda K
Hokkaido Igaku Zasshi; 1992 Jul; 67(4):462-74. PubMed ID: 1427592
[TBL] [Abstract][Full Text] [Related]
17. Inducible nitric oxide synthase neutralizes carbamoylating potential of 1,3-bis(2-chloroethyl)-1-nitrosourea in c6 glioma cells.
Yin JH; Yang DI; Chou H; Thompson EM; Xu J; Hsu CY
J Pharmacol Exp Ther; 2001 Apr; 297(1):308-15. PubMed ID: 11259558
[TBL] [Abstract][Full Text] [Related]
18. Boswellic acids inhibit glioma growth: a new treatment option?
Winking M; Sarikaya S; Rahmanian A; Jödicke A; Böker DK
J Neurooncol; 2000; 46(2):97-103. PubMed ID: 10894362
[TBL] [Abstract][Full Text] [Related]
19. Tumor heterogeneity and intrinsically chemoresistant subpopulations in freshly resected human malignant gliomas.
Shapiro JR; Mehta BM; Ebrahim SA; Scheck AC; Moots PL; Fiola MR
Basic Life Sci; 1991; 57():243-61; discussion 261-2. PubMed ID: 1814287
[No Abstract] [Full Text] [Related]
20. Cotreatment with a novel phosphoinositide analogue inhibitor and carmustine enhances chemotherapeutic efficacy by attenuating AKT activity in gliomas.
Van Meter TE; Broaddus WC; Cash D; Fillmore H
Cancer; 2006 Nov; 107(10):2446-54. PubMed ID: 17041888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
